These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
620 related articles for article (PubMed ID: 25516669)
1. Significance of downregulation of liver fatty acid-binding protein in hepatocellular carcinoma. Inoue M; Takahashi Y; Fujii T; Kitagawa M; Fukusato T World J Gastroenterol; 2014 Dec; 20(46):17541-51. PubMed ID: 25516669 [TBL] [Abstract][Full Text] [Related]
2. [Expression of liver-type fatty acid-binding protein and vascular endothelial growth factor and their correlation in human hepatocellular carcinoma]. Dong LH; Li H; Wang F; Li FQ; Zhou HY; Yang HJ Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):318-21. PubMed ID: 17425983 [TBL] [Abstract][Full Text] [Related]
3. Decreased expression of liver-type fatty acid-binding protein is associated with poor prognosis in hepatocellular carcinoma. Wang B; Tao X; Huang CZ; Liu JF; Ye YB; Huang AM Hepatogastroenterology; 2014; 61(133):1321-6. PubMed ID: 25436304 [TBL] [Abstract][Full Text] [Related]
4. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma. Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285 [TBL] [Abstract][Full Text] [Related]
5. Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry. Bioulac-Sage P; Rebouissou S; Thomas C; Blanc JF; Saric J; Sa Cunha A; Rullier A; Cubel G; Couchy G; Imbeaud S; Balabaud C; Zucman-Rossi J Hepatology; 2007 Sep; 46(3):740-8. PubMed ID: 17663417 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of SLC5A8 inhibits hepatocellular carcinoma progression through regulation of Wnt/β-catenin signaling. Hu BS; Xiong SM; Li G; Li JP Tumour Biol; 2016 Oct; 37(10):13445-13453. PubMed ID: 27465549 [TBL] [Abstract][Full Text] [Related]
7. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma. Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468 [TBL] [Abstract][Full Text] [Related]
8. Validation of a liver adenoma classification system in a tertiary referral centre: implications for clinical practice. van Aalten SM; Verheij J; Terkivatan T; Dwarkasing RS; de Man RA; Ijzermans JN J Hepatol; 2011 Jul; 55(1):120-5. PubMed ID: 21145863 [TBL] [Abstract][Full Text] [Related]
9. Fatty acid-binding protein 5 function in hepatocellular carcinoma through induction of epithelial-mesenchymal transition. Ohata T; Yokoo H; Kamiyama T; Fukai M; Aiyama T; Hatanaka Y; Hatanaka K; Wakayama K; Orimo T; Kakisaka T; Kobayashi N; Matsuno Y; Taketomi A Cancer Med; 2017 May; 6(5):1049-1061. PubMed ID: 28374947 [TBL] [Abstract][Full Text] [Related]
10. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma. Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236 [TBL] [Abstract][Full Text] [Related]
11. The Applicability of a Human Immunohistochemical Panel to Mouse Models of Hepatocellular Neoplasia. Salleng KJ; Revetta FL; Deane NG; Washington MK Comp Med; 2015 Oct; 65(5):398-408. PubMed ID: 26473343 [TBL] [Abstract][Full Text] [Related]
12. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
13. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma]. Liu Y; Chen X; Peng S; Fang H; Wu Y; Peng C; Shi L; Bai M; Xu B; Wang J; Deng G Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1553-6. PubMed ID: 12609066 [TBL] [Abstract][Full Text] [Related]
14. Utility of an immunohistochemical panel consisting of glypican-3, heat-shock protein-70, and glutamine synthetase in the distinction of low-grade hepatocellular carcinoma from hepatocellular adenoma. Lagana SM; Salomao M; Bao F; Moreira RK; Lefkowitch JH; Remotti HE Appl Immunohistochem Mol Morphol; 2013 Mar; 21(2):170-6. PubMed ID: 22914605 [TBL] [Abstract][Full Text] [Related]
15. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma. Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518 [TBL] [Abstract][Full Text] [Related]
16. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus. Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722 [TBL] [Abstract][Full Text] [Related]
17. [High expression of nucleophosmin/B23 in hepatocellular carcinoma]. Tian QH; Yun JP; Miao J; Chen G; Fu J; Zhang CQ; Su SG; Zhang MF; Wu QL Zhonghua Bing Li Xue Za Zhi; 2006 Jul; 35(7):407-11. PubMed ID: 17069676 [TBL] [Abstract][Full Text] [Related]
18. Liver fatty acid-binding protein (L-FABP) promotes cellular angiogenesis and migration in hepatocellular carcinoma. Ku CY; Liu YH; Lin HY; Lu SC; Lin JY Oncotarget; 2016 Apr; 7(14):18229-46. PubMed ID: 26919097 [TBL] [Abstract][Full Text] [Related]
19. [Expression of epidermal fatty acid-binding protein in cross-species hepatocellular carcinoma]. Shi JL; Cao J; Su JJ; Yang C; Ou C; Wang DP; Li Y Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):270-4. PubMed ID: 22964147 [TBL] [Abstract][Full Text] [Related]
20. Expression of liver fatty acid binding protein in hepatocellular carcinoma. Cho SJ; Ferrell LD; Gill RM Hum Pathol; 2016 Apr; 50():135-9. PubMed ID: 26997447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]